Enanta Pharmaceuticals saw the highest growth of 2.49% in patent filings in April and 2.66% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.49% and grants by 0.82%. GlobalData’s DataBook provides a comprehensive analysis of Enanta Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Enanta Pharmaceuticals has been focused on protecting inventions in United States(US) with 16 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 36% filings and 69% grants. The United States(US), South Korea(KR), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Enanta Pharmaceuticals is filings its patents. Among the top granted patent authorities, Enanta Pharmaceuticals has 69% of its grants in United States(US), 12% in Israel(IL) and 6% in South Korea(KR).
Roche and Johnson & Johnson could be the strongest competitors for Enanta Pharmaceuticals
Patents related to rare diseases and Covid-19 lead Enanta Pharmaceuticals's portfolio
Enanta Pharmaceuticals has the highest number of patents in rare diseases followed by, Covid-19 and climate change. For rare diseases, nearly 67% of patents were filed and 42% of patents were granted in Q2 2024.
Coronaviridae infections related patents lead Enanta Pharmaceuticals portfolio followed by non alcoholic fatty liver disease (nafld), and severe acute respiratory syndrome (sars)
Enanta Pharmaceuticals has highest number of patents in coronaviridae infections followed by non alcoholic fatty liver disease (nafld), severe acute respiratory syndrome (sars), cardiovascular disease, and non-alcoholic steatohepatitis (nash). For coronaviridae infections, nearly 3% of patents were filed and 3% of patents were granted in Q2 2024.
For comprehensive analysis of Enanta Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
